CORRECTION: Enento Group will publish January – September Interim Report on 29 October 2021
ENENTO GROUP PLC, INVESTOR NEWS 15 OCTOBER 2021 AT 11.45 EEST
CORRECTION: Enento Group will publish January– September Interim Report on 29 October 2021
Enento Group Plc will publish its Interim Report 1.1. – 30.9.2021 on Friday, 29 October 2021 at 12.00 EEST. The Interim Report will be available on Enento’s investor website https://enento.com/investors/ after publication.
Enento Group will hold a webcast for analysts, investors and media in English on the same day, where CEO Jukka Ruuska and CFO Elina Stråhlman will present the performance and events of the third quarter 2021.
Date and time: Friday, 29October 2021 at 3.00 p.m. EEST
You can follow the English webcast and conference call at:
To participate in the conference call, please dial in using one of the numbers below:
Finland: +358 (0) 9 4241 7514
Sweden: +46 (0) 8 1211 1105
United Kingdom: +44 (0) 330 027 1503
United States, Montgomery: +1 334-777-6981
The conference ID code: 716324
The presentation material will be available on the company’s investor website at 2.30 p.m. EEST and a recording of the webcast later during the day.
ENENTO GROUP PLC
For further information:
Investor Relations Manager
tel. +358 10 270 7056
Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
HMNC Brain Health to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference1.12.2021 16:37:31 CET | Press release
MUNICH, Germany, Dec. 01, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by predictive companion diagnostics, announced today that Chief Executive Officer, Benedikt von Braunmühl, Chief Clinical Development Officer, Dr. Hans Eriksson and Head of Operations, Dr. Maximilian Döbler will present at H.C. Wainwright’s 2nd Annual Psychedelics Conference on Monday, December 6th, 2021. In addition, Dr. Eriksson will participate in the ‘Future of Mental Healthcare’ panel at 2:30 p.m. Eastern Time. To attend, please register here. HMNC Brain Health’s virtual presentation will be available beginning Monday, December 6th at 7:00 a.m. Eastern Time and is accessible through the following webcast link: https://journey.ct.events/view/d77f2d7d-bff2-4d9a-8e89-620a24d1f35a. A webcast of the presentation will be available on the HMNC Brain Health Website for 90 days through the above webca
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab1.12.2021 15:03:00 CET | Press release
AGC Biologics to produce Procizumab for early and late clinical phases at company’s Chiba and Copenhagen facilities Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody Procizumab offers a new approach for the treatment of life-threatening diseases related to acute circulatory failure. Under the terms of the agreement, the companies will collaborate to transfer and optimize the manufacturing process for Procizumab. AGC Biologics will manufacture the clinical trial materials at its site in Chiba and transfer to its Copenhagen facility for all late phase activities including commercialization, to support early and late clinical phases and launch readiness of 4TEEN4’s monoclonal antibody. “We look forward to partnering with 4TEEN4
Kalmar’s proven straddle carrier technology to enhance operational capabilities at Kingston Freeport Terminal, Jamaica1.12.2021 15:00:00 CET | Press release
CARGOTEC CORPORATION, PRESS RELEASE, 1 DECEMBER 2021 AT 4 PM (EET) Kalmar, part of Cargotec, has signed a contract to supply the Kingston Freeport Terminal Limited (KFTL) with four diesel-electric straddle carriers for use at their terminal in Kingston, Jamaica. The order was booked in Cargotec's 2021 Q4 order intake with delivery scheduled to be completed during Q3 2022. KFTL is a strategic transhipment hub in the Caribbean, located at the exit of the Panama Canal and the crossroads of the North/South and East/West lines. The terminal was established in 2015, and it is part of Terminal Link, a joint venture between The CMA CGM Group, a world leader in shipping and logistics, and China Merchants Port (CMP). The four Kalmar Straddle Carriers are part of a progressive fleet renewal strategy geared to improve performance and reliability in the terminal's operation. KFTL’s equipment fleet already includes Kalmar straddle carriers, reachstackers, empty container handlers and terminal tracto
Sinch carries out second part of the directed new share issue of approximately 40 million shares announced on 30 September 20211.12.2021 14:50:00 CET | Press release
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Stockholm, Sweden – December 1, 2021 - Sinch AB (publ) (“Sinch” or the “Company”) carries out a directed new share issue through the issuance of 21 million new shares for a total consideration of approximately SEK 3,469 million. The new share issue constitutes the second part of the SEK 6.6 billion new share issue of in total 40,077,841 shares (the “Shares”) announced on 30 September 2021, the proceeds of which are used to partially fund the acquisition of Pathwire. The subscribers consisted of institutional investors, among others the Canada Pension Plan Investment Board (“CPP Investments”), Temasek, SeaTown Master Fund (“SeaTown”), and SB Northstar LP,
Sinch genomför den andra delen av den riktade nyemissionen om cirka 40 miljoner aktier som offentliggjordes den 30 september 20211.12.2021 14:50:00 CET | Pressemelding
EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUERING ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, JAPAN, AUSTRALIEN, SYDAFRIKA, NYA ZEELAND, HONGKONG, SINGAPORE ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTIONEN ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE KUNNA VARA OLAGLIG, KRÄVA YTTERLIGARE REGISTRERING ELLER ANDRA ÅTGÄRDER Stockholm, Sverige – 1 december 2021 – Sinch AB (publ) (“Sinch” eller “Bolaget”) genomför en riktad nyemission av 21 miljoner aktier mot en total teckningslikvid om cirka 3,469 miljarder kronor. Nyemissionen utgör den andra delen av den riktade nyemissionen om totalt cirka 6,6 miljarder kronor av 40 077 841 aktier (”Aktierna”) som offentliggjordes den 30 september 2021. Emissionslikviden från den riktade nyemissionen används för att delfinansiera förvärvet av Pathwire. Tecknarna bestod av institutionella investerare, däribland Canada Pension Plan Investment Board (”CPP Investments”), Temasek, SeaTown Master Fund (”Seatown
Voyager Closes Series A Funding, Marking $10M Raised1.12.2021 14:00:00 CET | Press release
Investment to fuel growth across the marine supply chain HOUSTON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Voyager Portal, a software platform enabling companies to reduce cost, risk, and complexity in their marine supply chain, has today announced an $8.4 million Series A investment, led by Phaze Ventures. Other new investors include ScOp Venture Capital, Waybury Capital and Flexport. All existing investors followed in on this round. The new funding comes on the back of unprecedented growth since the company raised $1.5 million in seed money two years ago. Since then, revenue has increased 13x from Q3 2020 to Q3 2021 and was up 40% from Q2 2021. Additionally, Voyager surpassed the $1 billion-mark for freight managed on the platform. Voyager's customers include manufacturers, traders and shippers in the renewable energy, commodity trading, mining and petrochemicals industries. “Voyager Portal was created to significantly reduce cost, risk, and complexity when transporting bulk materials aroun
Agreements entered into regarding the sale of three Volvo facilities in Norway1.12.2021 13:40:00 CET | Press release
Bilia has today, as part of the agreement with Volvo Cars dated 1 October 2021, entered into agreements to sell three facilities in Norway, in the Oslo area, to the newly established company Volvo Car Stor-Oslo AS. The three facilities are located in Økern, Fornebu and Lillestrøm and conduct sales of new cars, used cars and service for Volvo cars. The sale is expected to take place on 1 July 2022. The transfer is subject to approval by the Norwegian competition authority. Gothenburg, December 1, 2021 Bilia AB (publ) For information please contact: Per Avander, Managing Director and CEO, +46 (0)10 497 70 00, email@example.com Kristina Franzén, CFO, +46 (0)10 497 73 40, firstname.lastname@example.org Facts about the Bilia Group Bilia is one of Europe’s largest car dealers with a leading position within service and sales of cars, transport vehicles and trucks. Bilia has about 160 facilities in Sweden, Norway, Germany, Luxembourg and Belgium. Bilia sells cars of the brand Volvo, BMW, Toyota,